A study published in August 2019 lent support to the growing number of lawsuits against Injectafer, confirming that the drug can cause hypophosphatemia (HPP), a condition in which phosphorus levels in the body become dangerously low. This condition is linked to severe health complications, including muscle weakness and bone pain, which were central to many of the claims brought against the manufacturer.

AFFF

By submitting your cell phone number, you agree to receive marketing messages from LegalLawsuit.com and its partners—Email Agency, Waypoint Software, CAG, La Logic, and Shapiro Law Group—via voice calls, AI-generated calls, text messaging, or other automated methods. For details on how we use your information, please refer to our Privacy Policy.